Fetal heart defects: Potential and pitfalls of first-trimester detection

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 5, 2013, Pages 251-260

  Khalil, Asma ^a   Nicolaides, Kypros H ^a,b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Congenital heart defects; Ductus venosus; Echocardiography; Fetal; First trimester; Nuchal translucency; Tricuspid regurgitation

Indexed keywords

ABDOMINAL AORTA; ANEUPLOIDY; AORTA STENOSIS; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BIRTH DEFECT; CONGENITAL HEART MALFORMATION; DUCTUS VENOSUS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; FETUS DISEASE; FETUS HEART; FIRST TRIMESTER PREGNANCY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT MORTALITY; INTERRUPTED AORTIC ARCH; MITRAL VALVE ATRESIA; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; TRANSVAGINAL ECHOGRAPHY; TRICUSPID VALVE ATRESIA; TRICUSPID VALVE REGURGITATION;

CONGENITAL HEART DEFECTS; DUCTUS VENOSUS; ECHOCARDIOGRAPHY; FETAL; FIRST TRIMESTER; NUCHAL TRANSLUCENCY; TRICUSPID REGURGITATION;

BIOLOGICAL MARKERS; FEMALE; FETAL DEVELOPMENT; FETAL HEART; HEART DEFECTS, CONGENITAL; HUMANS; MALE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, PRENATAL;

EID: 84884351899     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.05.004     Document Type: Article

References (63)

1. Mensah G.A., Brown D.W. An overview of cardiovascular disease burden in the United States. Health Affairs 2007, 26:38-48.
2. Garne E., Dolk H., Loane M., Boyd P.A. EUROCAT website data on prenatal detection rates of congenital anomalies. JMed Screen 2010, 17:97-98.
3. Syngelaki A., Chelemen T., Dagklis T., Allan L., Nicolaides K.H. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011, 31:90-102.
4. D'Ottavio G., Mandruzzato G., Meir Y.J., Rustico M.A., Fischer-Tamaro L., Conoscenti G. Comparison of first trimester and second trimester screening for fetal anomalies. Ann NY Acad Sci 1998, 847:200-209.
5. Taipale P., Ammala M., Salonen R., Hilesmaa V. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation. Acta Obstet Gynecol Scand 2004, 83:1141-1146.
6. Chen M., Lam Y.H., Lee C.P., Tang M.H. Ultrasound screening of fetal structural abnormalities at 12 to 14 weeks in Hong Kong. Prenat Diagn 2004, 24:92-97.
7. Cedergren M., Selbing A. Detection of fetal structural abnormalities by an 11-14-week ultrasound dating scan in an unselected Swedish population. Acta Obstet Gynecol Scand 2006, 85:912-915.
8. Volpe P., Ubaldo P., Volpe N., et al. Fetal cardiac evaluation at 11-14 weeks by experienced obstetricians in a low-risk population. Prenat Diagn 2011, 31:1054-1061.
9. Kornman L.H., Wortelboer M.J.M., Beekhuis J.R., Morssink L.P., Mantingh A. Women's opinions and the implications of first-versus second-trimester screening for fetal Down's syndrome. Prenat Diagn 1997, 17:1011-1018.
10. Statistical Bulletin 2009/1 2009, Department of Health. Abortion Statistics, England and Wales: 2008, DoH, London.
11. Hernádi L., Töröcsik M. Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population. Prenat Diagn 1997, 17:753-759.
12. Hyett J., Perdu M., Sharland G., Snijders R., Nicolaides K.H. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999, 318:81-85.
13. Bilardo C.M., Pajkrt E., de Graaf I., Mol B.W., Bleker O.P. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 1998, 11:401-406.
14. Hafner E., Schuchter K., Liebhart E., Philipp K. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenat Diagn 1998, 18:29-34.
15. Chen M., Lee C.P., Lam Y.H.H., et al. Comparison of nuchal and detailed morphology ultrasound examinations in early pregnancy for fetal structural abnormality screening: a randomized controlled trial. Ultrasound Obstet Gynecol 2008, 31:136-146.
16. Dane B., Dane C., Sivri D., Kiray M., Cetin A., Yayla M. Ultrasound screening for fetal major abnormalities at 11-14 weeks. Acta Obstet Gynecol Scand 2007, 86:666-670.
17. Mavrides E., Cobian-Sanchez F., Tekay A., et al. Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001, 17:106-110.
18. Michailidis G.D., Economides D.L. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 2001, 17:102-105.
19. Schwarzler P., Carvalho J.S., Senat M.V., Masroor T., Campbell S., Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999, 106:1029-1034.
20. Orvos H., Wyadaka K., Kozinszky Y.Z., Katona M., Pal A., Szabo J. Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience. Eur J Obstet Gynecol Reprod Biol 2002, 101:124-128.
21. Bahado-Singh R.O., Wapner R., Thom E., et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 2005, 192:1357-1361.
22. Bruns R.F., Moron A.F., Murta C.G.V., Goncalves L.F.A., Zamith M.M. The role of nuchal translucency in the screening of congenital heart defects. Arq Bras Cardiol 2006, 87:272-279.
23. Becker R., Wagner R.D. Detailed screening for fetal anomalies and cardiac defects at the 11-13 weeks scan. Ultrasound Obstet Gynecol 2006, 27:613-618.
24. Westin M., Saltvedt S., Almstro H., Grunewald C., Valentin L. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16 260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol 2007, 29:150-158.
25. Muller M.A., Clur S.A., Timmerman E., Bilardo C.M. Nuchal translucency measurement and congenital heart defects: models association in low-risk pregnancies. Prenat Diagn 2007, 27:164-169.
26. Oztekin O., Oztekin D., Týnar S., Adýbelli Z. Ultrasonographic diagnosis of fetal structural abnormalities in prenatal screening at 11-14 weeks. Diagn Interv Radiol 2009, 15:221-225.
27. Hildebrand E., Selbing A., Blomberg M. Comparison of first and second trimester ultrasound screening for fetal anomalies in the southeast region of Sweden. Acta Obstet Gynecol Scand 2010, 89:1412-1419.
28. Grande M., Arigita M., Borobio V., Jimenez J.M., Fernandez S., Borrell A. First-trimester detection of structural abnormalities and the role of aneuploidy markers. Ultrasound Obstet Gynecol 2012, 39:157-163.
29. Carvalho J.S., Mavrides E., Shinebourne A.E., Campbell S., Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002, 88:387-391.
30. Westin M., Saltvedt S., Bergman G., Almstro H., Grunewald C., Valentin L. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses. Ultrasound Obstet Gynecol 2006, 27:632-639.
31. Borrell A., Robinson J.N., Santolaya-Forgas J. Clinical value of the 11- to 13+6-week sonogram for detection of congenital malformations: a review. Am J Perinatol 2011, 28:117-124.
32. Allan L., Cook A., Huggon I. First trimester fetal heart scanning. Fetal echocardiography - a practical guide 2009, 190-202. Cambridge University Press, Cambridge. L. Allan, A. Cook, I. Huggon (Eds.).
33. von Kaisenberg C.S., Kuhling-von Kaisenberg H., Fritzer E., Schemm S., Meinhold-Heerlein I., Jonat W. Fetal transabdominal anatomy scanning using standard views at 11 to 14 weeks' gestation. Am J Obstet Gynecol 2005, 192:535-542.
34. Lombardi C.M., Bellotti M., Fesslova V., Cappellini A. Fetal echocardiography at the time of the nuchal translucency scan. Ultrasound Obstet Gynecol 2007, 29:249-257.
35. Persico N., Moratalla J., Lombardi C.M., Zidere V., Allan L., Nicolaides K.H. Fetal echocardiography at 11-13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet Gynecol 2011, 37:296-301.
36. Bennasar M., Martínez J.M., Olivella A., et al. Feasibility and accuracy of fetal echocardiography using four-dimensional spatiotemporal image correlation technology before 16 weeks' gestation. Ultrasound Obstet Gynecol 2009, 33:645-651.
37. Vinals F., Ascenzo R., Naveas R., Huggon I., Giuliano A. Fetal echocardiography at 11+0 to 13+6 weeks using four-dimensional spatiotemporal image correlation telemedicine via an Internet link: a pilot study. Ultrasound Obstet Gynecol 2008, 31:633-638.
38. Turan S., Turan O.M., TY-Torredes K., Harman C.R., Baschat A.A. Standardization of the first-trimester fetal cardiac examination using spatiotemporal image correlation with tomographic ultrasound and color Doppler imaging. Ultrasound Obstet Gynecol 2009, 33:652-656.
39. Smrcek J.M., Berg C., Geipel A., et al. Detection rate of early fetal echocardiography and in utero development of congenital heart defects. JUltrasound Med 2006, 25:187-196.
40. Haak M.C., Twisk J.W.R., Van Vught M.G. How successful is fetal echocardiography examination in the first trimester of pregnancy?. Ultrasound Obstet Gynecol 2002, 20:9-13.
41. Vimpelli T., Huhtala H., Acharya G. Fetal echocardiography during routine first-trimester screening: a feasibility study in an unselected population. Prenat Diagn 2006, 26:475-482.
42. Hyett J., Moscoso G., Papapanagiotou G., Perdu M., Nicolaides K.H. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996, 7:245-250.
43. Hyett J.A., Brizot M.L., Von Kaisenberg C.S., McKie A.T., Farzaneh F., Nicolaides K.H. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol 1996, 87:506-610.
44. Simpson J.M., Sharland G.K. Nuchal translucency and congenital heart defects: heart failure or not?. Ultrasound Obstet Gynecol 2000, 16:30-36.
45. Atzei A., Gajewska K., Huggon I.C., Allan L., Nicolaides K.H. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005, 26:154-157.
46. Makrydimas G., Sotiriadis A., Hugon I.C., et al. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005, 192:89-95.
47. Makrydimas G., Sotiriadis A., Ioannidis J.P. Screening performance of ff{ligature}rst-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003, 189:1330-1335.
48. Snijders R.J., Noble P., Sebire N.J., Souka A.P., Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998, 352:343-346.
49. Souka A.P., Krampl E., Bakalis S., Heath V., Nicolaides K.H. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the ff{ligature}rst trimester. Ultrasound Obstet Gynecol 2001, 18:9-17.
50. Kiserud T., Eik-Nes S.H., Hellevik L.R., Blaas H.-G. Ductus venosus blood velocity changes in fetal cardiac diseases. JMatern Fetal Invest 1993, 3:15-20.
51. Kiserud T., Eik-Nes S.H., Blaas H.-G., Hellevik L.R., Simensen B. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol 1994, 4:109-114.
52. Matias A., Huggon I., Areias J.C., Montenegro N., Nicolaides K.H. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999, 14:307-310.
53. Papatheodorou S.I., Evangelou E., Makrydimas G., Ioannidis J.P. First-trimester ductus venosus screening for cardiac defects: a meta-analysis. Br J Obstet Gynaecol 2011, 118:1438-1445.
54. Maiz N., Plasencia W., Dagklis T., Faros E., Nicolaides K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008, 31:256-260.
55. Borrell A., Grande M., Bennasar M., et al. First trimester detection of cardiac defects with the use of ductus venosus blood flow. Ultrasound Obstet Gynecol 2012 Nov, [Epub ahead of print]. 10.1002/uog.12349.
56. Martínez J.M., Comas M., Borrell A., et al. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol 2010, 35:267-272.
57. Berg C., Kremer C., Geipel A., Kohl T., Germer U., Gembruch U. Ductus venosus blood flow alterations in fetuses with obstructive lesions of the right heart. Ultrasound Obstet Gynecol 2006, 28:137-142.
58. Gardiner H.M., Belmar C., Tulzer G., et al. Morphologic and functional predictors of eventual circulation in the fetus with pulmonary atresia or critical pulmonary stenosis with intact septum. JAm Coll Cardiol 2008, 51:1299-1308.
59. Huggon I.C., DeFigueiredo D.B., Allan L.D. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003, 89:1071-1073.
60. +6 weeks of gestataion. Ultrasound Obstet Gynecol 2009, 33:18-22.
61. Pereira S., Ganapathy R., Syngelaki A., Maiz N., Nicolaides K.H. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 2011, 117:1384-1391.
62. Llurba E., Syngelaki A., Sánchez O., Carreras E., Cabero L., Nicolaides K. Maternal serum placental growth factor at 11-13 weeks' gestation and fetal cardiac defects. Ultrasound Obstet Gynecol 2012, [Epub ahead of print]. 10.1002/uog.12346.
63. Jelliffe-Pawlowski L., Baer R., Moon-Grady A.J., Currier R.J. Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects. Prenat Diagn 2011, 31:466-472.